WerringDJOzkanHDoubalF, et al. Early neurological deterioration in acute lacunar ischemic stroke: systematic review of incidence, mechanisms, and prospects for treatment. Int J Stroke, 2024; 20: 7–20.
2.
MarkusHSDe LeeuwFE.Cerebral small vessel disease: recent advances and future directions. Int J Stroke2023; 18: 4–14.
3.
BarowEBoutitieFChengB, et al.; WAKE-UP Investigators. Functional outcome of intravenous thrombolysis in patients with lacunar infarcts in the WAKE-UP trial. JAMA Neurol2019; 76: 641–649.
4.
KaraszewskiBWyszomirskiAJabłońskiBWerringDJTomakaD.Efficacy and safety of intravenous rtPA in ischemic strokes due to small-vessel occlusion: systematic review and meta-analysis. Transl Stroke Res2021; 12: 406–415.
5.
MarkusHS.When to start of anticoagulation after stroke and alternative thrombolytic agents: highlights at World Stroke Congress 2024. Int J Stroke2024; 19: 1080–1082.
6.
BestJGArramLAhmedN, et al.; OPTIMAS Investigators. Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): protocol for a randomized controlled trial. Int J Stroke2022; 17: 583–589.
7.
WerringDDehbiH-MAhmedN, et al. Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial; on behalf of the OPTIMAS investigators. Lancet. Epub ahead of print 23 October 2024. DOI: 10.1016/S0140-6736(24)02197-4.
8.
Mota TellesJPCenciGIMarinheiroG, et al. Anticoagulation strategy for patients presenting with ischemic strokes while using a direct oral anticoagulant: a systematic review and meta-analysis. Int J Stroke, 2024; 20: 42–52.
9.
OkekunleAPJonesSAdenijiO, et al. Stroke in Africa: a systematic review and meta-analysis of the incidence and case-fatality rates. Int J Stroke2023; 18: 634–644.
10.
YoukeeDDeenGFBaldehM, et al. Stroke in Sierra Leone: case fatality rate and functional outcome after stroke in Freetown. Int J Stroke2023; 18: 672–680.
11.
MatujaSSNgimbwaJAndrewL, et al. Stroke characteristics and outcomes in urban Tanzania: data from the Prospective Lake Zone Stroke Registry. Int J Stroke2024; 19: 536–546.
12.
RoushdyTArefHKesraouiS, et al. Stroke services in Africa: what is there and what is needed. Int J Stroke2022; 17: 972–982.
13.
YoukeeDBaldehMRuddA, et al. A scoping review of stroke registers in Sub-Saharan Africa. Int J Stroke, 2024; 20: 21–28.
14.
AnåkerAKevdzijaMElfM.Enriched environments in stroke units: defining characteristics and limitations. HERD2024; 17: 344–359.
15.
HanPPHanYShenXYGaoZKBiX.Enriched environment-induced neuroplasticity in ischemic stroke and its underlying mechanisms. Front Cell Neurosci2023; 17: 1210361.
16.
QinHReidIGorelikANgL.Environmental enrichment for stroke and other non-progressive brain injury. Cochrane Database Syst Rev2021; 11: CD011879.
17.
BernhardtJLipson-SmithRDavisA, et al. Why hospital design matters: a narrative review of built environments research relevant to stroke care. Int J Stroke2022; 17: 370–377.
18.
BishopLBrownSCGardenerHE, et al. The association between social networks and functional recovery after stroke. Int J Stroke, 2024; 20: 95–104.
